Cancer News and Research

Latest Cancer News and Research

Scientists establish biomarker strategy to diagnose variety of cancer types

A team of biologists, clinical oncologists, pathologists and information scientists has established a strategy for identifying biomarkers. If a particular pattern of these biomarkers can be detected in the blood, this indicates a cancerous disease. An interdisciplinary research breakthrough that opens many doors.

18 Feb 2011

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.

18 Feb 2011

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.

18 Feb 2011

Retired NC judge calls for full compensation on medical malpractice damages

A new bill designed to limit the rights of patients injured by medical malpractice is dangerous because it puts patients at risk, according to a bipartisan group that shared stories and opinions at a public hearing, as well as unconstitutional.

18 Feb 2011

UNC, Cleveland Clinic choose Carefx Physician Insight Plus tool for performance improvement

Carefx Corp., a leading provider of interoperable workflow solutions, announced today that the University of North Carolina Hospitals has chosen Fusionfx Physician Insight Plus™, one of many performance improvement dashboards offered by Carefx and developed in collaboration with Cleveland Clinic.

18 Feb 2011

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.

18 Feb 2011

Scottsdale Healthcare implants MRI-safe pacemaker

Scottsdale Healthcare Shea Medical Center is the first hospital in the southwestern United States to implant an MRI-safe pacemaker, a major technological breakthrough for patients who need MRI diagnostic scans, which can damage older style pacemakers or cause serious health complications.

18 Feb 2011

Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty

A rinsing technique with betadine that costs just a little over one dollar per patient may significantly reduce the infection rate following total knee and hip joint replacement surgery according to a study by researchers at Rush University Medical Center.

18 Feb 2011

RyMed's InVision-Plus IV Connector decreases catheter-related bloodstream infections by 92.6%

Georgia Health Sciences University, Augusta, GA exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies' zero displacement InVision-Plus® IV Connector significantly decreased the incidence of catheter-related bloodstream infections (CR-BSIs) by 92.6% on average when compared to a simple split septum with negative displacement IV connector (Becton-Dickinson Q-Syte®) and a reversed split-septum device with negative displacement IV connector (ICU Medical Clave®).

18 Feb 2011

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.

18 Feb 2011

BDSI announces over 50% enrolled in BEMA Buprenorphine Phase 3 study in chronic pain

BioDelivery Sciences International, Inc. announced today that enrollment of its Phase 3 trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain is on schedule, with over half of the needed subjects enrolled.

18 Feb 2011

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Endo Pharmaceuticals and Bioniche Life Sciences Inc. today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348.

18 Feb 2011

Smoking, exercise influence Vitamin E's effect on pneumonia risk

Depending on the level of smoking and leisure time exercise, vitamin E supplementation may decrease or increase, or may have no effect, on the risk of pneumonia, according to a study published in Clinical Epidemiology.

18 Feb 2011

State roundup: Gov't workers face benefit changes; worry over social service cuts

For many states, 2011 is the most trying budget year of a fiscal crisis now in its fourth year. Revenues generally remain lower than what they used to be; widespread joblessness is putting unprecedented strains on safety-net programs like Medicaid; and all this is happening as federal stimulus money runs out.

18 Feb 2011

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Apricus Biosciences, Inc., announced today that it is currently in discussions with the U.S. Food and Drug Administration ("FDA") relating to the PrevOnco™ Special Protocol Assessment ("SPA") Phase III protocol submitted by the Company in December 2010.

18 Feb 2011

Avenir team discovers how Neisseria meningitidis disseminates into bloodstream

Although, in the majority of cases, the localized presence of Neisseria meningitidis in the throat has no consequence, it can sometimes lead to meningitis or septicaemia. The seriousness of these two infections is driving researchers from around the world to improve their understanding of the mode of operation of this bacterium, which, once it leaves its favourite location becomes extremely dangerous.

18 Feb 2011

Cancer News and Research

Latest Cancer News and Research

Scientists establish biomarker strategy to diagnose variety of cancer types

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

Retired NC judge calls for full compensation on medical malpractice damages

UNC, Cleveland Clinic choose Carefx Physician Insight Plus tool for performance improvement

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

Scottsdale Healthcare implants MRI-safe pacemaker

Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty

RyMed's InVision-Plus IV Connector decreases catheter-related bloodstream infections by 92.6%

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

BDSI announces over 50% enrolled in BEMA Buprenorphine Phase 3 study in chronic pain

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Smoking, exercise influence Vitamin E's effect on pneumonia risk

State roundup: Gov't workers face benefit changes; worry over social service cuts

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Avenir team discovers how Neisseria meningitidis disseminates into bloodstream

World's first cancer stem cell-targeting chemical missile

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

Viewpoints: Arizona's waiver; next gen's 'different' Medicare?; individual mandate's constitutionality

Research: Higher levels of social activity linked to less disability in old age

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in